Gerrit Dispersyn

Gerrit Dispersyn is the current President and Chief Executive Officer at RXi Pharmaceuticals. Prior to this, they served as President & Chief Operating Officer at Phio Pharmaceuticals Corp. from November 2018 to March 2019. Gerrit has also held the position of Chief Development Officer at RXi Pharmaceuticals Corporation from April 2017 to November 2018. Dispersyn's other previous companies include ingress, LLC and Integra LifeSciences, where they served as VP, Global Head of Clinical Affairs from June 2014 to April 2017, and VP, Program Management & Clinical Affairs from November 2008 to April 2017 respectively. Gerrit also has experience in Business Development, having served as Director of Barrier Therapeutics from January 2004 to December 2006, and later as VP, Product Development & Portfolio Management from July 2002 to October 2008.

Gerrit Dispersyn's educational career includes a PhD in Medical Sciences from Maastricht University, an MSc in Biochemistry from the University of Antwerp, and a postgraduate degree in Biomedical Imaging from the University of Antwerp.

Some direct reports include Caitlin Kontulis - VP of Finance and Administration, James Cardia - VP of Business Operations.